Daniel Martin, MD
Orthopedic Surgery · Saint Louis, MONPI 1710092275
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $304 and has fallen 92.3% since, to $23 in 2025.
Across 50 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$209
- Ferring Pharmaceuticals Inc.$97
- Johnson & Johnson$71
- Pacira Therapeutics, Inc.$65
- Heraeus Medical, LLC.$53
- Amgen$52
- plus $466 from 18 others
What the payments were for
- Food & beverage$1,014100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $209 |
| Ferring Pharmaceuticals Inc. | 7 | $97 |
| Johnson & Johnson(2 entities) | 4 | $71 |
| Pacira Therapeutics, Inc. | 4 | $65 |
| Heraeus Medical, LLC. | 2 | $53 |
| Amgen(2 entities) | 4 | $52 |
| Smith+Nephew | 2 | $47 |
| Elite Orthopedics, LLC | 1 | $41 |
| Convatec Inc. | 2 | $39 |
| KCI USA, Inc. | 2 | $37 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Highridge Medical LLC | 2 | $34 |
| Zimvie Inc. | 2 | $28 |
| Bioventus LLC | 1 | $26 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Medacta USA, Inc. | 1 | $23 |
| Medtronic | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Zimmer Biomet | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Arteriocyte Medical Systems, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Abbott | 1 | $12 |
How this compares
Too few orthopedic surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 438 | $4,014 |
| Celecoxib | 160 | $2,979 |
| Oxycodone Hcl | 458 | $2,894 |
| Cephalexin | 292 | $873 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $667 |
| Tramadol Hcl | 148 | $561 |
| Methylprednisolone | 35 | $182 |
| Ondansetron OdtOndansetron | 21 | $163 |
| Clindamycin Hcl | 57 | $156 |
| Meloxicam | 39 | $103 |
| Gabapentin | 14 | $100 |
| Cyclobenzaprine Hcl | 12 | $77 |
| Prednisone | 15 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Saint Louis
- Leo WhitesideSaint Louis$500K
- Zachary BurnettSaint Louis$56K
- Richard LehmanSaint Louis$5K
- Alan MorrisSaint Louis$0
- Robert MarkensonSaint Louis$0
- John KrauseChesterfield$7K
- Steven SmithNorth Kansas City$4K
- Mitchell RotmanChesterfield$2K
- James ReardonNorth Kansas City$1K
- Hee LeeColumbia$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.